Purinostat mesylate - CAS 2650188-32-0

Purinostat mesylate is a selective HDAC inhibitor. purinostat mesylate inhibits type I and type IIb HDACs (IC50: 0.81-11.5 nM) . purinostat mesylate affects the cell cycle of LAMA84 and 188 BL-2 cells and induces apoptosis, showing a strong anti-leukaemic effect in vivo. purinostat mesylate has been used to study lymphocytic leukaemia. Purinostat mesylate can be used to study lymphocytic leukaemia.

Others, Apoptosis, HDAC

Others, Chromatin/Epigenetic, Apoptosis, DNA Damage/DNA Repair

2650156

C24H30N10O6S

586.63

CS(O)(=O)=O.CN(Cc1nc2c(nc(nc2n1C)-c1ccc(N)cc1)N1CCOCC1)c1ncc(cn1)C(=O)NO

-20°C

Ice Packs

Small Compound